secwatch.observer — SEC 8-K summary
======================================

Issuer:     Septerna, Inc. (SEPN)
CIK:        0001984086
Form:       8-K
Filed at:   2026-08-25T12:15:05+00:00
Accession:  0001193125-26-364210
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Septerna appoints Rajiv Patni, M.D., as Chief Medical Officer, effective Aug 24, 2026
--------------------------------------------------------------------------------

- Rajiv Patni, M.D., named CMO effective August 24, 2026; announcement press release dated August 25, 2026.
- Patni brings 25+ years in biopharma; joins from Judo Bio where he was CEO, previously CRO at Reata.
- He was CMO at Global Blood Therapeutics, Portola, Adamas, and Actelion; contributed to 10 regulatory approvals.
- CEO Jeffrey Finer: Patni's experience will help advance Septerna's GPCR oral medicine pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1984086/000119312526364210/0001193125-26-364210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1984086/000119312526364210/d172697d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-364210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer